The company said revenues from its non-invasive heart transplant rejection test AlloMap rose about 16 percent year over year.
Linkage is now part of Thermo Fisher's transplant diagnostics business, One Lambda. Linkage's flagship product line is its real-time PCR technology, LinkSeq.
In PNAS this week: sand rat genome assembly, algorithm for human leukocyte antigen typing from short-read data, and more.
In Science this week: a protective gene in C. elegans, and combining EHRs with genetic data to ID HLA-associated variants
An international team of researchers has mapped new associations between HLA mutations and specific diseases, and made their data freely accessible.
The company said revenues for the quarter and full-year 2016 included sales of Olerup HLA typing products, which CareDx got through its acquisition of Allenex.
GenDx is planning to get CE marking for an Ion Torrent-based HLA typing workflow, to add to the firm's set of NGS solutions for transplant diagnostics.
CareDx's CareDx Pty subsidiary said it will pay up to $735,000 to Conexio as a percentage of revenues from products acquired in the deal.
Under the terms of the agreement, GenDx can resell Illumina's instruments, reagents, and maintenance contracts for the field of HLA sequencing.
The contract was awarded by the UK's NHS Blood and Transplant, which is responsible for promoting and overseeing organ and blood donation.
A University of California, Los Angeles-led team has found turning off the CCR5 gene could improve recovery after a stroke, according to Scientific American.
South Dakota lawmakers are to weigh a bill aimed at teaching the strengths and weaknesses of scientific concepts, the Associated Press and KEVN-Black Hills Fox report.
In Science this week: the synthetic genetic system hachimoji, and more.
Thermo Fisher Scientific says it will no longer sell machines in China's Xinjiang region, according to the Wall Street Journal.